Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Radiation Induced Esophagitis in NSCLC
NCT06120803Phase 2Recruiting
- Sponsor
- Rush University Medical Center
- Start
- Mar 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of esomeprazole in radiation esophagitis, sponsored by Rush University Medical Center. Started Mar 2024; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
radiation esophagitis
Beyond the preview
Go deeper on NCT06120803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120803.